BC Week In Review | Jan 20, 2017
Company News

APT Therapeutics, AZ deal

The companies partnered to develop APT's APT102 . APT will receive an upfront payment and is eligible for development milestones. AstraZeneca, which has an option to acquire the product, will fund trials of APT102 to treat...
BC Innovations | Sep 11, 2014
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Thrombosis Ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3; CD39L3) In vitro and canine studies suggest engineered ENTPD3 can help prevent thrombosis. Extracellular ATP, which has proinflammatory...
BioCentury | May 10, 2004
Finance

Midwest work ethic

Midwest work ethic Company Location Round Proposed amt ($M) Focus Notes APT St. Louis, Mo. B $8.0 Stroke Hopes the proceeds will provide about two years of runway and allow it to submit INDs for...
Items per page:
1 - 3 of 3